Table 2. Percentage of human retinal pigment epithelial cell line (ARPE-19) cells in each cell-cycle after release with aphidicolin treatment.
Cell cycle phase | EGF Mean±SD | EGF+GlcN 2.5 mM Mean±SD | EGF+GlcN 5.0 mM Mean±SD |
---|---|---|---|
G0/G1 | |||
0 h |
79.2±3.96 |
80.66±4.03 |
82.01±4.1 |
4 h |
25.5±1.27 |
22.43±1.12 |
23.27±1.16 |
8 h |
42.09±2.1 |
29.05±1.45 |
25.29±1.26 |
12 h |
77.72±3.89 |
76.63±3.83 |
60.99±3.05 |
S | |||
0 h |
15.54±0.78 |
11.66±0.58 |
9.13±0.46 |
4 h |
55.95±2.8 |
67.42±3.37 |
70.79±3.54 |
8 h |
8.03±0.4 |
25.57±1.28 |
30.46±1.52 |
12 h |
12.69±0.63 |
5.95±0.3 |
9.41±0.47 |
G2/M | |||
0 h |
5.27±0.26 |
7.69±0.38 |
8.87±0.44 |
4 h |
18.55±0.93 |
10.15±0.51 |
5.94±0.3 |
8 h |
49.88±2.49 |
45.38±2.27 |
44.25±2.21 |
12 h | 9.59±0.48 | 17.42±0.87 | 29.6±1.48 |
Abbreviations: EGF represents epidermal growth factor; SD represents standard deviation.